Package 25021-839-20

Brand: acetazolamide

Generic: acetazolamide sodium
NDC Package

Package Facts

Identity

Package NDC 25021-839-20
Digits Only 2502183920
Product NDC 25021-839
Product ID 25021-839_2b64b799-67b1-41b7-ad0d-7c160c6efd58
Description

1 VIAL in 1 CARTON (25021-839-20) / 5 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2026-01-15
Brand acetazolamide
Generic acetazolamide sodium
Sample Package No

Linked Drug Pages (1)

Acetazolamide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2b64b799-67b1-41b7-ad0d-7c160c6efd58", "openfda": {"unii": ["429ZT169UH"], "rxcui": ["307702"], "spl_set_id": ["58093032-8480-4d0f-82be-92e643bdbea4"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-839-20)  / 5 mL in 1 VIAL", "package_ndc": "25021-839-20", "marketing_start_date": "20260115"}], "brand_name": "Acetazolamide", "product_id": "25021-839_2b64b799-67b1-41b7-ad0d-7c160c6efd58", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "25021-839", "generic_name": "Acetazolamide Sodium", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE SODIUM", "strength": "500 mg/5mL"}], "application_number": "ANDA219775", "marketing_category": "ANDA", "marketing_start_date": "20260115", "listing_expiration_date": "20271231"}